Blog Posts by Daniel Haag, PhD

    Head of Neuroscience at Neucyte
    As the Head of Neuroscience and Co-founder, Dr. Daniel Haag drives the scientific direction of NeuCyte Inc. and leads the development of novel human neural in vitro platforms for neurotoxicity assessment and drug discovery.
    Drug Discovery

    How SynFire® Technology can benefit your research

    Daniel Haag, PhD / 26 November 2019

    Subscribe to recieve updates